Skip to main content
. Author manuscript; available in PMC: 2016 Mar 10.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2015 Jun 9;8(4):338–346. doi: 10.1161/CIRCOUTCOMES.114.001335

Table 1.

Baseline characteristics and health-related quality-of-life scores

NRCA TA-TAVR (n=875) RCT TA-TAVR (n=99) p-value* RCT SAVR (n=80) p-value*
Demographic and clinical characteristics
 Age (years) 84.6 ± 6.3 82.6 ± 6.9 <0.01 83.4 ± 5.5 0.02
 Male (%) 47.1 51.5 0.40 58.8 0.05
 STS Score 12.0 ± 4.2 11.8 ± 3.7 0.64 11.8 ± 3.1 0.70
 Previous MI (%) 29.4 28.3 0.82 36.3 0.20
 Prior CABG (%) 51.1 50.5 0.91 57.5 0.27
 Prior PCI (%) 46.6 32.3 <0.01 43.0 0.55
 Prior BAV (%) 28.6 12.1 <0.01 12.5 <0.01
 LV ejection fraction (%) 52.2 ± 12.6 53.1 ± 12.3 0.50 53.3 ± 10.8 0.44
 Cerebrovascular Disease (%) 29.9 41.8 0.02 33.3 0.54
 Peripheral Vascular Disease (%) 61.7 62.2 0.91 63.3 0.78
 Diabetes Mellitus (%) 35.0 40.4 0.28 48.8 0.01
 Renal Disease (Cr ≥ 2 mg/dL)(%) 16.7 13.1 0.36 22.5 0.19
 Liver Disease (%) 2.7 2.0 0.67 0.0 0.13
 COPD (Oxygen dependent) (%) 8.7 12.1 0.26 8.8 0.98
 Major arrhythmia (%) 48.5 53.5 0.34 47.5 0.86
 Permanent pacemaker (%) 21.3 20.2 0.80 21.3 0.99
 Pulmonary hypertension (%) 36.8 46.5 0.06 29.1 0.17
Quality-of-life scores
 KCCQ Summary 44.2 ± 21.5 40.6 ± 22.1 0.11 45.4 ± 19.7 0.64
 KCCQ Physical Limitation 41.6 ± 24.5 41.2 ± 24.3 0.89 48.1 ± 23.4 0.03
 KCCQ Total Symptoms 55.7 ± 22.8 49.6 ± 23.3 0.01 54.3 ± 21.6 0.61
 KCCQ Quality of Life 40.2 ± 23.6 35.0 ± 26.6 0.04 39.7 ± 22.2 0.85
 KCCQ Social Limitation 37.4 ± 28.2 35.3 ± 30.1 0.51 39.4 ± 26.9 0.54
 SF-12 Physical 31.4 ± 8.1 29.4 ± 7.4 0.02 31.8 ± 8.6 0.69
 SF-12 Mental 48.2 ± 11.2 46.8 ± 11.4 0.24 48.4 ± 9.6 0.86
 EQ-5D Utilities 0.68 ± 0.19 0.67 ± 0.19 0.61 0.72 ± 0.17 0.12
*

p-values relate to the comparison with NRCA TA-TAVR

Values are mean ± SD or %.

BAV = balloon aortic valvuloplasty; CABG = coronary artery bypass grafting; COPD = chronic obstructive pulmonary disease; EQ-5D = EuroQol 5D; KCCQ = Kansas City Cardiomyopathy Questionnaire; LV = left ventricular; MI = myocardial infarction; NRCA = non-randomized continued access registry; PCI = percutaneous coronary intervention; SAVR = surgical aortic valve replacement; SF-12 = Medical Outcomes Study Short-Form 12; STS = Society of Thoracic Surgeons; TA = transapical; TAVR = transcatheter aortic valve replacement.